Avatar photo

Lily Chang

3061 Posts
What trends are shaping personalized medicine and clinical trial design?

How genomics and data science are reshaping personalized medicine and clinical trial design

Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological, environmental, and lifestyle characteristics of each patient. Over the past decade, this approach has moved from concept to practice, reshaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health are accelerating this transformation, while regulatory agencies and healthcare systems adapt to support more precise and patient-centered research models.Genomics and Multi-Omics as Foundational DriversThe steep drop in genome sequencing costs, paired with the expanding use of multi-omics approaches, has significantly transformed personalized medicine.Genomics: Through whole-genome and exome sequencing, researchers…
Read More
How are AI and protein folding tools accelerating drug discovery?

overcoming drug discovery challenges with AI and protein folding

Drug discovery has traditionally been a slow, expensive, and high-risk process, often taking more than a decade and billions of dollars to bring a single therapy to market. Recent advances in artificial intelligence and protein folding tools are reshaping this landscape by dramatically improving how scientists understand biological targets, design drug candidates, and predict outcomes. Together, these technologies are compressing timelines, lowering costs, and opening therapeutic opportunities that were previously out of reach.The Central Role of Protein Structure in Drug DiscoveryMost medications exert their effects by attaching to specific proteins and modifying how those proteins function, and creating potent molecules…
Read More
How are regulators shaping sustainable finance product design?

Redesigning investment services to meet new regulatory standards

Sustainable finance has shifted from a niche concern to a mainstream priority, driven largely by regulatory action. By imposing disclosure requirements, developing classification frameworks, setting product oversight rules, and issuing supervisory guidance, authorities are reshaping how financial offerings are designed, organized, promoted, and evaluated. This pressure is prompting a broad overhaul of investment funds, loans, bonds, insurance solutions, and advisory services so they better reflect environmental and social goals while shielding investors from deceptive claims.Regulatory Objectives Behind Sustainable Product DesignRegulators are advancing a set of interrelated objectives that have a direct impact on product design.Market integrity: Discouraging deceptive sustainability assertions…
Read More
How do companies quantify reputational risk in valuation models?

Quantifying intangible assets like reputation for accurate valuation

Reputational risk describes the possible decline in a company’s value that arises when stakeholders’ views worsen in response to actual or perceived situations, such as ethical lapses, regulatory violations, faulty products, data protection issues, or environmental damage, and because reputation shapes customer confidence, pricing leverage, talent retention, and the ability to secure capital, it has become a significant element in assessing corporate worth.Modern valuation models increasingly attempt to quantify reputational risk rather than treating it as a purely qualitative concern. While reputation itself is intangible, its financial consequences are observable, measurable, and often persistent.Why Reputational Risk Must Be QuantifiedInvestors and…
Read More